Is There A Written Description Requirement After All?
On Dec. 7, 2009, the U.S. Court of Appeals for the Federal Circuit convened en banc and heard arguments in a case of potential major importance to patent law, Ariad Pharms....To view the full article, register now.
Already a subscriber? Click here to view full article